GL1X · GenesisL1 explorer

MolNFT v1 · #157156 · protein

Mapping the binding trajectory of a suicide inhibitor in human indoleamine 2,3-dioxygenase 1

6MQ6: “Mapping the binding trajectory of a suicide inhibitor in human indoleamine 2,3-dioxygenase 1”. X-ray diffraction, 2 ligands (HEM, H7P), 5 pockets (best druggability 0.83). MolNFT v1 #157156 on GenesisL1: 3D structure, binding sites…

PDB
6MQ6
Type
protein
Length
737 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Indoleamine 2,3-dioxygenase 1
EC
1.13.11.52
UniProt
P14902
Ligands
HEM, H7P
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 60% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIndoleamine 2,3-dioxygenase 1 (EC 1.13.11.52)protein37161% helix, 4% strandP14902
BIndoleamine 2,3-dioxygenase 1 (EC 1.13.11.52)protein36660% helix, 3% strandP14902

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • H7P · (2R)-N-(4-chlorophenyl)-2-[cis-4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide · ligand · chains B
  • GOL · Glycerol · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111920.830.84130empty
26300.810.8553H7P, GOL
35970.780.8351HEM, GOL
4560.280.7417GOL
5530.270.7316GOL

Interfaces

1 interface between chains.

  • A–B · 723 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6MQ6 · Mapping the binding trajectory of a suicide inhibitor in human indoleamine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.